1787 related articles for article (PubMed ID: 19595394)
1. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.
Delhaye C; Maluenda G; Wakabayashi K; Ben-Dor I; Lemesle G; Collins SD; Syed AI; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):826-32. PubMed ID: 20211326
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation.
Park DW; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Circulation; 2009 Nov; 120(20):1987-95. PubMed ID: 19884467
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
Schoos MM; Kelbæk H; Kofoed KF; Køber L; Kløvgaard L; Helqvist S; Engstrøm T; Saunamäki K; Jørgensen E; Holmvang L; Clemmensen P
Am J Cardiol; 2011 Jun; 107(11):1597-603. PubMed ID: 21439539
[TBL] [Abstract][Full Text] [Related]
7. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.
Applegate RJ; Sacrinty MT; Kutcher MA; Santos RM; Gandhi SK; Little WC
Circ Cardiovasc Interv; 2009 Feb; 2(1):35-42. PubMed ID: 20031691
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical effects of magnetic resonance imaging in patients with coronary artery stent implantation.
Kaya MG; Okyay K; Yazici H; Sen N; Tavil Y; Turkoglu S; Timurkaynak T; Ozdemir M; Cemri M; Yalcin R; Cengel A
Coron Artery Dis; 2009 Mar; 20(2):138-42. PubMed ID: 19247183
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
10. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
[TBL] [Abstract][Full Text] [Related]
11. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
13. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS;
Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730
[TBL] [Abstract][Full Text] [Related]
16. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
[TBL] [Abstract][Full Text] [Related]
17. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
[TBL] [Abstract][Full Text] [Related]
18. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
[TBL] [Abstract][Full Text] [Related]
19. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
